These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2429363)

  • 1. Transient vinblastine-induced thrombocytopenia during chemotherapy with vinblastine, cis-platinum and bleomycin.
    Abrahamsen AF; Klepp O; Fosså SD; Sønstevold A
    Scand J Haematol; 1986 Jul; 37(1):44-9. PubMed ID: 2429363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced platelet survival following chemotherapy with vinblastine, bleomycin and cis-platinum for testicular teratoma.
    Rees GJ; Slade RR; Hopes P
    Eur J Cancer Clin Oncol; 1982 Nov; 18(11):1125-9. PubMed ID: 6186497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early-onset thrombocytopenia during combination chemotherapy in testicular cancer is induced by vinblastine.
    Steurer G; Kuzmits R; Pavelka M; Sinzinger H; Fritz E; Ludwig H
    Cancer; 1989 Jan; 63(1):51-8. PubMed ID: 2463070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with PVB in non seminomatous germ-cell cancer of the testis.
    Jacquillat C; Auclerc G; Auclerc MF; Verges J; Weil M
    Prog Clin Biol Res; 1985; 203():451-6. PubMed ID: 2421336
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment Results of Extracranial Malignant Germ Cell Tumor with Regimens of Cisplatin, Vinblastine, Bleomycin or Carboplatin, Etoposide, and Bleomycin with Special Emphasis on the Sites of Vagina and Testis.
    Hou JY; Liu HC; Yeh TC; Sheu JC; Chen KH; Chang CY; Liang DC
    Pediatr Neonatol; 2015 Oct; 56(5):301-6. PubMed ID: 25769700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis: a Southwest Oncology Group study.
    Wozniak AJ; Samson MK; Shah NT; Crawford ED; Ford CD; Altman SJ; Stephens RL; Natale RB; Bouroncle BA; Blumenstein BA
    J Clin Oncol; 1991 Jan; 9(1):70-6. PubMed ID: 1702148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum for advanced germ cell testis tumors: Brazilian experience.
    Srougi M; Simon SD; de Góes GM
    J Urol; 1985 Jul; 134(1):65-9. PubMed ID: 2409300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment results of stage III germinal testicular tumors.
    Akdaş A; Kirkali Z; Altuğ U; Ilker Y
    Turk J Pediatr; 1984; 26(1-4):301-6. PubMed ID: 6085662
    [No Abstract]   [Full Text] [Related]  

  • 9. Selected use of aggressive adjuvant chemotherapy in resected stage II nonseminomatous germ cell tumors of the testis.
    Pizzocaro G
    Prog Clin Biol Res; 1985; 203():585-90. PubMed ID: 2421344
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemotherapy with adriamycin and vincristine alternated with cyclophosphamide and actinomycin D in testicular germ cell tumors refractory to cisplatin, vinblastine and bleomycin.
    Crispino S; Pizzocaro G; Marchini S; Monfardini S
    Eur J Cancer Clin Oncol; 1986 Mar; 22(3):251-6. PubMed ID: 2423339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential trials of cisplatin, vinblastine, and bleomycin and etoposide and cisplatin in disseminated nonseminomatous germ cell tumors of the testis with a good prognosis at a single institution.
    Germá JR; Sagarra AF; Izquierdo MA; Seguí MA
    Cancer; 1993 Feb; 71(3):796-803. PubMed ID: 7679314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced male non-seminomatous germ-cell tumours. Combination chemotherapy with cis-platinum, vinblastine and bleomycin.
    Woods RL; Fox RM; Tattersall MH
    Med J Aust; 1979 Dec; 2(12):630-2. PubMed ID: 94148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bleomycin in germ cell testicular tumors (GCTT).
    Germa Lluch JR
    Prog Clin Biol Res; 1985; 203():381-9. PubMed ID: 2421332
    [No Abstract]   [Full Text] [Related]  

  • 14. Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer.
    Einhorn LH; Donohue J
    Ann Intern Med; 1977 Sep; 87(3):293-8. PubMed ID: 71004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renovascular hypertension after combination chemotherapy for testicular cancer.
    Wright LF; Reese EP; Bicknell SL
    J Urol; 1988 Jan; 139(1):134-5. PubMed ID: 2447295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vinblastine, cisplatin and bleomycin treatment of advanced nonseminomatous testicular tumors.
    Bodrogi I; Baki M; Horti J; Liszka G; Ottó S; Hindy I; Sugár J; Eckhardt S
    Neoplasma; 1990; 37(4):445-50. PubMed ID: 1700311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum combination chemotherapy in metastatic testis cancer--a 1-year program.
    Vugrin D; Whitmore WF; Golbey RB
    J Urol; 1982 Dec; 128(6):1205-8. PubMed ID: 6185697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic chemotherapy with cyclophosphamide, doxorubicin, and cisplatin plus vinblastine and bleomycin in advanced germinal tumors. Results with 100 patients.
    Logothetis CJ; Samuels ML; Selig DE; Ogden S; Dexeus F; Swanson D; Johnson D; von Eschenbach A
    Am J Med; 1986 Aug; 81(2):219-28. PubMed ID: 2426944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects on renal function and blood pressure of treatment with cisplatin, vinblastine, and bleomycin in patients with germ cell cancer.
    Hansen SW; Groth S; Daugaard G; Rossing N; Rørth M
    J Clin Oncol; 1988 Nov; 6(11):1728-31. PubMed ID: 2460594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raynaud's phenomenon and cryoglobulinemia during chemotherapy for testicular carcinoma.
    Dunlop PR; Hendy-Ibbs PM
    Cancer Treat Rep; 1983 Mar; 67(3):317-8. PubMed ID: 6187453
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.